The HCFO program ended in December 2016.
This site will no longer be updated, and some elements may not appear correctly.
Medicare Spending on HMOs and Stand-Alone Drug Plans: What is it Worth to Beneficiaries?
PrintDownload:
November 2008
What are the costs and benefits of supporting private Medicare health insurance plans? Steven D. Pizer, Ph.D., and colleagues examined how well stand-alone prescription drug plans and increased payments to HMOs improved the welfare of Medicare beneficiaries per dollar of additional federal spending. They found that the stand-alone prescription drug plans generate more value per government dollar. Learn more in the HCFO Findings Brief.